KR19980703866A - Disinfectant Disinfectant for Throat - Google Patents

Disinfectant Disinfectant for Throat Download PDF

Info

Publication number
KR19980703866A
KR19980703866A KR1019970707266A KR19970707266A KR19980703866A KR 19980703866 A KR19980703866 A KR 19980703866A KR 1019970707266 A KR1019970707266 A KR 1019970707266A KR 19970707266 A KR19970707266 A KR 19970707266A KR 19980703866 A KR19980703866 A KR 19980703866A
Authority
KR
South Korea
Prior art keywords
disinfectant
throat
acid
dipotassium
present
Prior art date
Application number
KR1019970707266A
Other languages
Korean (ko)
Inventor
이나기도시오
가네바코마코토
신카와야스히로
Original Assignee
미와요시히로
코와가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미와요시히로, 코와가부시키가이샤 filed Critical 미와요시히로
Publication of KR19980703866A publication Critical patent/KR19980703866A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

본 발명은 포비돈 요드 및 글리시리친산디칼륨을 함유하는 것을 특징으로 하는 인후용 살균소독제에 관한 것이다. 본 발명품은 사용감이 우수하고, 또한 안정성이 양호하다.The present invention relates to a bactericidal disinfectant for throat characterized by containing povidone iodine and glycosyl dipotassium. The present invention has excellent usability and good stability.

Description

인후용 살균소독약Disinfectant Disinfectant for Throat

포비돈 요드를 유효성분으로 하는 인후용 살균소독약으로서는 희석 수용액으로의 구강 세척제나 루골액(Lugol's solution)과 같이 직접 인후에 도포하는 제제이외에 최근 시판되는 간이 분무형 또는 토출형 용기에 의해 인후에 직접 부착시키는 액제가 알려져 있다.As a disinfectant disinfectant for the throat with povidone iodine as an active ingredient, it is directly attached to the throat by a recently sprayed or discharged container which is commercially available in addition to a formulation applied directly to the throat, such as a mouthwash in a dilute aqueous solution or a rugol's solution. Known liquids are known.

그러나, 이들 인후용 살균소독약은 쓴맛, 자극감, 작열감 등이 있기 때문에 유아, 어린이, 노인 등이 사용하는 경우에는 목이 메이거나, 기침을 하거나 또는 구역질을 하는 것이 많기 때문에 목적하는 효과가 충분이 얻어지지 못하는 문제가 있었다.However, these disinfectant disinfectants for throat have a bitter taste, irritation, burning sensation, so that when used by infants, children, the elderly, etc. are often thirsty, coughing or nausea, the desired effect is not obtained. There was no problem.

이와 같은 문제의 원인으로서는 포비돈 요드 자체의 문제로서 포비돈 요등 중의 유효 요드에 의한 소양감, 작열감 등의 부작용이외에 제제중에 함유된 휘발성 물질의 양, 기제 성분에 의한 자극 등이 고려되고 있다.As a cause of such a problem, as a problem of povidone iodine itself, besides side effects such as pruritus and burning sensation caused by effective iodine in povidone urea, the amount of volatile substances contained in the preparation, stimulation by base component, and the like are considered.

포비돈 요드 자체의 문제는 제제설계상에서 해결하지 않으면 안되나, 유효 요드의 성질, 안정성 등의 점에서 배합성분이 제한되어 있다.The problem of povidone iodine itself must be solved in the formulation design, but the compounding ingredients are limited in terms of the properties and stability of the effective iodine.

예를 들면, 포비돈 요드 제제의 자극을 마스킹하기 위하여 제제학상 일반적으로 사용되고 있는 성분, 예를 들면 감미료로서 자당, 과당, 포도당, 유당, 맥아당 등의 당류를 배합하면, 양성분이 상승적으로 분해하여 버린다. 또한, 향료를 배합하는 경우에는 다량으로 배합하지 않으면 효과가 얻어질 수 없으나, 이들을 다량으로 배합하면, 용해성, 맛, 사용감 등의 점에서 문제가 생기게 된다.For example, in order to mask the stimulus of the povidone iodine preparation, when a component generally used in the pharmaceutical formulation, for example, a sweetener such as sucrose, fructose, glucose, lactose, maltose and the like, is added, the nutrient is synergistically decomposed. In addition, in the case of blending the fragrance, the effect can not be obtained if not blended in a large amount, but if they are blended in a large amount, there is a problem in terms of solubility, taste, usability and the like.

따라서 본 발명의 목적은 사용감이 우수하고, 또한 포비돈 요드가 안정한 인후용 살균소독샹을 제공하는 것이다.Accordingly, an object of the present invention is to provide a disinfectant disinfectant champ for throat that has excellent usability and is stable in povidone iodine.

본 발명은 감미를 가지며, 자극 및 작열감이 개선되고, 사용감이 우수하며, 더욱이 성분의 안정성이 양호한 살균소독약에 관한 것이다.The present invention relates to a bactericidal disinfectant which has sweetness, improves stimulus and burning sensation, has excellent usability, and further has good stability of the ingredient.

도 1은 유효 요드 및 글리시리친산 디칼륨의 안정성에 대한 pH의 영향을 나타내는 도이다.1 is a diagram showing the effect of pH on the stability of effective iodine and dipotassium glycyricitate.

이러한 실정에서, 본 발명자들은 감초 엑기스의 감미와 교미 작용에 주목하고, 각종 엑기스류, 추출성문, 기타 염류에 대하여 포비돈 요드 용액중의 배합 가능성을 검토한 결과, 포비돈 요드와 글리시리친산 디칼륨을 조합하여 사용하면 포비돈 요드의 살균작용에 영향을 주지 않고, 사용감이 우수하며, 더욱이 안정한 인후용 살균 소독약이 얻어짐을 발견하고, 본 발명을 완성하였다.In this situation, the present inventors pay attention to the sweetening and mating action of licorice extract, and examined the possibility of mixing in povidone iodine solution with various extracts, extracts, and other salts, When used in combination, it was found that a sterilizing disinfectant for a throat can be obtained without affecting the sterilization action of povidone iodine, and thus, a stable throat disinfectant.

또한, 감초 엑기스류에 대하여는 사용감의 개선효과는 어느 정도 있으나, 유효 요드의 활성을 저하시켜버리기 때문에 살균작용이 얻어질수 없어서 배합이 곤란하였다. 글리시리친산, 글리시리친산 모노암모늄, 글리시리친산 모노칼륨, 글리시르레틴산, 글리시리친산 스테아릴 및 스테아린산 글리시르레틸에 대하여는 용해량이 적고, 사용감을 개선하는 목적이 달성할 수 없어서, 배합이 곤란하였다. 또한, 3-숙시닐옥시글리시르레틴산 2나트륨은 유효 요드의 활성을 저하시키기 때문에, 살균작용이 얻어질 수 없으므로 배합이 곤란하다.In addition, the licorice extract has some effect of improving the feeling of use, but since the activity of the effective iodine is lowered, sterilization cannot be obtained, and thus it is difficult to mix. Glycyric acid, monosilicate glycyric acid, monopotassium glycyric acid, glycyrrhetinic acid, stearyl glycyric acid stearyl, and stearic acid glycyryl are less soluble, and the purpose of improving the feeling of use cannot be achieved. It was difficult. In addition, since disodium 3-succinyloxyglycile retinate lowers the activity of the effective iodine, since sterilization cannot be obtained, compounding is difficult.

즉, 본 발명은 포비돈 요드 및 글리시리친산 디칼륨을 함유하는 것을 특징으로 하는 인후용 살균소독약을 제공하는 것이다.That is, the present invention is to provide a bactericidal disinfectant for throat characterized in that it contains povidone iodine and glycidyl dipotassium.

본 발명의 인후용 살균소독약에서 포비돈 요드는 전조성중에 0.05 내지 1 w/v%, 특히, 0.3 내지 0.6 w/v% 배합하는 것이 바람직하다.In the throat disinfectant for throat of the present invention, povidone iodine is preferably blended at 0.05 to 1 w / v%, in particular, at 0.3 to 0.6 w / v%, in the precursor composition.

또한 글리시리친산 디칼륨은 조성중에 0.05 내지 1 w/v%, 특히 0.2 내지 0.4 w/v% 배합하는 것이 바람직하고, 이 범위내이면, 감미가 있으며, 사용감이 보다 우수한 것임이 얻어질 수 있다.In addition, dipotassium glycyric acid is preferably blended at 0.05 to 1 w / v%, especially 0.2 to 0.4 w / v% in the composition, and if it is within this range, it can be obtained that it is sweet and has better usability. .

또한, 글리시리친산 디칼륨으로서는 일본 약국방 외규준 또는 화장원료기준에 기재되어 있는 것을 사용할 수 있다.As the potassium dicytolic acid diacrylate, those described in the Japanese Pharmacy Room Standard or Cosmetic Ingredient Standard can be used.

본 발명의 인후용 살균소독약은 기제 성분(용매)에 포비돈 요드 및 글리시리친산 디칼륨을 용해함으로서 제조된다. 여기서 사용되는 기제 성분(용매)으로서는 예를 들면, 정제수, 에탄올, 프로필렌글리콜, 글리세린 등을 들 수 있으며, 이들의 1종 또는 2종이상을 조합하여 사용할 수 있다.The antiseptic disinfectant for throat of the present invention is prepared by dissolving povidone iodine and glycosyric acid dipotassium in the base component (solvent). As a base component (solvent) used here, purified water, ethanol, propylene glycol, glycerin, etc. are mentioned, for example, These can be used 1 type or in combination or 2 or more types.

또한, 본 발명의 인후용 살균소돌약에는 상기 필수 성분이외에 예를 들면 회향유, 스피어민트유, dl-캠퍼, l-멘톨, 계피유, 페퍼민트유, 바니린, 스트로베리 엑기스 등의 착향제, 향료; 염화 리소짐, 알란토인 및 트란넥삼산 등의 활성성분 등을 본 발명의 효과를 손상하지 않는 범위로 적의 배합할 수 있다.In addition, the bactericidal antiseptic drug for throat of the present invention includes, for example, fennel oil, spearmint oil, dl-camphor, l-menthol, cinnamon oil, peppermint oil, vanillin, strawberry extract and other flavoring agents; Active ingredients such as lysozyme chloride, allantoin, and transnecsamic acid and the like can be suitably blended in a range not impairing the effects of the present invention.

또한, 본 발명의 인후용 살균소독약은 pH가 3 내지 5, 특히 pH 3.5 내지 4.5이면, 포비돈 요드 및 글리시리친산 디칼륨의 안정성이 더욱 높아져 바람직하다. 여기서 pH 를 조정하는데 사용하는 pH조정제로서는 예를 들면, 염산, 붕산, 인산 등의 무기산, 아세트산, 젖산, 시트르산 등의 유기산, 아스코르빈산, 시트르산 2나트륨, 인산 2수소칼륨, 아미노아세트산 등의 완충제를 들 수 있다. 이들의 pH 조정제는 소망의 pH로 하는 데 필요한 양을 첨가하면 좋다.In addition, the bactericidal disinfectant for a throat of the present invention is preferably at a pH of 3 to 5, particularly at a pH of 3.5 to 4.5, because the stability of povidone iodide and glycosyric acid dipotassium is further enhanced. As the pH adjuster used to adjust the pH here, for example, inorganic acids such as hydrochloric acid, boric acid, phosphoric acid, organic acids such as acetic acid, lactic acid, citric acid, ascorbic acid, disodium citrate, potassium dihydrogen phosphate, amino acetic acid, etc. Can be mentioned. What is necessary is just to add the quantity of these pH adjusters necessary for setting it as desired pH.

본 발명의 인후용 살균소독약은 예를 들면 에탄올 및 정제수의 혼액에 포비돈 요드 및 글리시리친산 디칼륨을 용해하고, 농 글리세틸을 가하여 교반하고, pH 조정제로 pH를 3-5로 조정함으로서 제조하는 것이 바람직하다.The antiseptic disinfectant for throat of the present invention is prepared by dissolving povidone iodine and glycositrate dipotassium in a mixture of ethanol and purified water, stirring by adding concentrated glyceryl, and adjusting the pH to 3-5 with a pH adjuster. It is preferable.

이하 실시예를 들어 본 발명을 더 구체적으로 설명하나, 본 발명은 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples.

실시예 1.Example 1.

표 1에 나타낸 조성의 인후용 살균소독약을 제조하고, 미각에 의한 관능시험을 행하였다. 결과를 표 2에 나타낸다.A bactericidal disinfectant for throat having the composition shown in Table 1 was prepared, and a sensory test by taste was performed. The results are shown in Table 2.

(제법)(quite)

에탄올 및 정제수의 혼합액에 포비돈 요드, 글리시리친산 디칼륨, 요드화칼륨 및 l-멘톨을 용해하고, 농 글리세린 및 염산을 가하고, 교반하고, 정제수로 100 ㎖로 하였다.Povidone iodine, dipotassium glycyric acid, potassium iodide, and l-menthol were dissolved in a mixed solution of ethanol and purified water, concentrated glycerin and hydrochloric acid were added, stirred, and 100 ml of purified water was used.

(관능시험방법)(Sensory test method)

각 살균소독약을 간이 분부형 용기(25 ㎖)에 충전하고, 7명의 패널러의 인후에 2회 직사하였을 때의 미각을 불쾌한 쓴맛이 있다, 쓴맛이 있다, 약간 쓴맛이 있다, 약간 단맛이 있다 및 불쾌한 단맛이 있다의 하나로 평가하고, 결과를 그의 사람수로 나타냈다.Each bactericidal disinfectant is packed into a simple divided container (25 ml), and the taste of the two direct panelists when exposed directly to the throat is unpleasant bitter, bitter, slightly bitter, slightly sweet and It was evaluated as one of the unpleasant sweetness, and the result was expressed by his number of people.

성분ingredient 본 발명품Invention 비교품Comparative product 1One 22 33 44 포비돈 요드글리시리친산디칼륨요드화칼륨ℓ-멘톨농 글리세린에탄올염산정제수Povidone-iodine glycidyl dipotassium potassium iodide 1-menthol concentrate glycerin ethanol hydrochloric acid 0.45 g0.05 g1.0 g0.3 g80.0 g15.0 g적량*총100㎖0.45 g0.05 g1.0 g0.3 g80.0 g 15.0 g quantity * total 100 ml 0.45 g0.2 g1.0 g0.3 g80.0 g15.0 g적량*총100㎖0.45 g0.2 g1.0 g0.3 g80.0 g15.0 g quantity * total 100 ml 0.45 g0.5 g1.0 g0.3 g80.0 g15.0 g적량*총100㎖0.45 g0.5 g1.0 g0.3 g80.0 g15.0 g quantity * total 100 ml 0.45 g1.0 g1.0 g0.3 g80.0 g15.0 g적량*총100㎖0.45 g1.0 g1.0 g0.3 g80.0 g 15.0 g quantity * total 100 ml 0.45 g-1.0 g0.3 g80.0 g15.0 g적량*총100㎖0.45 g-1.0 g 0.3 g 80.0 g 15.0 g quantity * total 100 ml

회답(인)Answer (person) 본 발명품Invention 비교품Comparative product 1One 22 33 44 불쾌한 쓴맛이 있다.It has an unpleasant bitter taste. 00 00 00 00 1One 쓴맛이 있다.It has a bitter taste. 00 00 00 00 44 약간 쓴맛이 있다.It is slightly bitter. 1One 00 00 00 22 약간 단맛이 있다.It is slightly sweet. 33 1One 1One 00 00 단맛이 있다.It is sweet. 33 66 66 66 00 불쾌한 단맛이 있다.It has an unpleasant sweetness. 00 00 00 1One 00

표 2의 결과로부터 명백한 바와 같이, 글리시틸리친산 디칼륨을 배합하지 않은 비교품에서는 쓴맛이 있으며, 사용감이 나쁜 것에 대하여, 글리시틸리친산 디칼륨을 0.05 내지 1.0 w/v% 배합한 본 발명품에서는 모두 단맛이 있으며, 우수한 사용감을 나타냈다.As is apparent from the results in Table 2, the comparative product which did not contain dipotassium glycidyl titanate had a bitter taste, and the present invention which blended 0.05 to 1.0 w / v% of dipotassium glycidyl titanate with respect to poor usability. All have sweet taste and showed excellent usability.

실시예 2Example 2

표 3에 나타낸 조성의 인후용 살균 소독약을 실시예 1과 동일하게 하여 pH 2 내지 6으로 제조했다. 이를 60℃에서 1주간 보존하였을 때의 pH에 의한 유효 요드 및 글리시틸리친산 디칼륨의 안정성에 대한 영향을 조사했다. 결과를 잔존율로 도 1에 나타내었다.Throat bactericidal disinfectants of the compositions shown in Table 3 were prepared in the same manner as in Example 1 to pH 2 to 6. The effect on the stability of effective iodine and glycidyl titanic acid potassium by pH when it was preserve | saved at 60 degreeC for 1 week was investigated. The results are shown in Figure 1 by the residual rate.

성분ingredient 본 발명품Invention 55 66 포비돈 요드글리시딜리친산 디칼륨요드화칼륨ℓ-멘톨농 글리세린에탄올pH 조정제정제수Povidone Iodiglycidyl Litrate Dipotassium Potassium Iodide 1- Menthol Glycerin Ethanol pH 0.2 g0.2 g1.0 g0.3 g80.0 g15.0 g염산총100 ㎖0.2 g0.2 g1.0 g0.3 g80.0 g15.0 g total hydrochloric acid 100 ml 0.2 g0.2 g1.0 g0.3 g80.0 g15.0 g시트르산총100 ㎖0.2 g0.2 g1.0 g0.3 g80.0 g15.0 g total citric acid 100 ml

도 1의 결과로부터 명백한 바와 같이 본 발명의 인후용 살균소독약은 pH 3 내지 5의 범위에서 유효 요드의 안정성은 pH가 알카리측으로 기울어 나쁘게 되나, 글리시딜리친산 디칼륨의 안정성은 pH가 산성측으로 기울어 나쁘게 되어, 양성분은 상반되는 안정성의 거동을 나타내나, 이 범위에서는 충분한 안정성이 얻어진다.As is apparent from the results of Figure 1, the bactericidal disinfectant for throat of the present invention is effective in the stability of the effective iodine in the pH range of 3 to 5, the pH is worse inclined toward the alkali side, the stability of dipotassium glycidyl lysate is inclined toward the acidic side It becomes bad, and a positive component shows the opposite behavior of stability, but sufficient stability is obtained in this range.

실시예 3Example 3

표 4에 나타난 조성의 인후용 살균소독약을 실시예 1과 동일하게 제조하고, 실시예 1과 동일하게 미각에 의한 관능시험을 행하였다. 결과를 표 5에 나타낸다.A bactericidal disinfectant for throat of the composition shown in Table 4 was prepared in the same manner as in Example 1, and a sensory test by taste was performed in the same manner as in Example 1. The results are shown in Table 5.

성분ingredient 본 발명품Invention 77 88 99 1010 포비돈 요드글리시리친산디칼륨요드화칼륨ℓ-멘톨농 글리세린에탄올염산정제수Povidone-iodine glycidyl dipotassium potassium iodide 1-menthol concentrate glycerin ethanol hydrochloric acid 0.05 g0.2 g1.0 g0.3 g80.0 g15.0 g적량*총100㎖0.05 g 0.2 g 1.0 g 0.3 g 80.0 g 15.0 g quantity * total 100 ml 0.1 g0.2 g1.0 g0.3 g80.0 g15.0 g적량*총100㎖0.1 g0.2 g1.0 g0.3 g80.0 g15.0 g quantity * total 100 ml 0.7 g0.2 g1.0 g0.3 g80.0 g15.0 g적량*총100㎖0.7 g 0.2 g 1.0 g 0.3 g 80.0 g 15.0 g quantity * total 100 ml 1.0 g0.2 g1.0 g0.3 g80.0 g15.0 g적량*총100㎖1.0 g0.2 g1.0 g0.3 g80.0 g15.0 g quantity * total 100 ml

* : pH 4로 되는 양*: amount to pH 4

회답(인)Answer (person) 본 발명품Invention 77 88 99 1010 불쾌한 쓴맛이 있다.It has an unpleasant bitter taste. 00 00 00 00 쓴맛이 있다.It has a bitter taste. 00 00 00 00 약간 쓴맛이 있다.It is slightly bitter. 00 00 00 00 약간 단맛이 있다.It is slightly sweet. 00 1One 00 22 단맛이 있다.It is sweet. 77 66 77 55 불쾌한 단맛이 있다.It has an unpleasant sweetness. 00 00 00 00

표 5의 결과로부터 명백한 바와 같이, 본 발명품은 모두 감미가 있으며, 사용감이 우수하며, 또한 안정성에서도 우수한 것이었다.As apparent from the results in Table 5, all of the present invention was sweet, excellent in use, and excellent in stability.

본 발명의 인후용 살균소독약은 감미를 가지며, 자극 및 작열감이 개선되고, 사용이 우수함과 동시에 성분의 안정성도 양호한 것이다.The antiseptic disinfectant for throat of the present invention has sweetness, improves stimulus and burning sensation, is excellent in use, and has good stability of components.

Claims (6)

포비돈 요드 및 글리시리친산디칼륨을 함유하는 것을 특징으로 하는 인후용 살균소독제.A bactericidal disinfectant for throat, comprising povidone iodine and glycosyl dipotassium. 제 1항에 있어서, 포비돈 요드를 0.05 내지 1 w/v% 및 글리시리친산디칼륨0.05 내지 1 w/v%를 함유하는 것을 특징으로 하는 인후용 살균소독제.The throat disinfectant for throat according to claim 1, wherein the povidone iodine contains 0.05 to 1 w / v% and 0.05 to 1 w / v% of dipotassium glycyric acid. 제 1항 또는 제 2항에 있어서, pH가 3 내지 5인 것을 특징으로 하는 인후용 살균소독제.The throat disinfectant for throat according to claim 1 or 2, wherein the pH is 3 to 5. 제 1항 내지 제 3항의 어느 한 항에 있어서, 추가로 용매를 함유하는 것을 특징으로 하는 인후용 살균소독제.The disinfectant disinfectant for throat according to any one of claims 1 to 3, further comprising a solvent. 제 4항에 있어서, 용매가 물, 에탄올, 프로필렌글리콜 및 글리세린으로 구성된 군에서 선택된 1종 또는 그 이상인 것을 특징으로 하는 인후용 살균소독제.The disinfectant disinfectant for throat according to claim 4, wherein the solvent is one or more selected from the group consisting of water, ethanol, propylene glycol and glycerin. 제 1항 내지 제 5항의 어느 한 항에 있어서, 추가로 용매화제, 향미제, 향료 및 소염제를 함유하는 것을 특징으로 하는 인후용 살균소독제.The disinfectant disinfectant for throat according to any one of claims 1 to 5, further comprising a solvating agent, a flavoring agent, a flavoring agent, and an anti-inflammatory agent.
KR1019970707266A 1995-05-08 1996-04-26 Disinfectant Disinfectant for Throat KR19980703866A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7109350A JPH08301774A (en) 1995-05-08 1995-05-08 Throat disinfectant
JP109350/1995 1995-05-08

Publications (1)

Publication Number Publication Date
KR19980703866A true KR19980703866A (en) 1998-12-05

Family

ID=14508007

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970707266A KR19980703866A (en) 1995-05-08 1996-04-26 Disinfectant Disinfectant for Throat

Country Status (6)

Country Link
JP (1) JPH08301774A (en)
KR (1) KR19980703866A (en)
CN (1) CN1089589C (en)
AU (1) AU5515196A (en)
TW (1) TW363890B (en)
WO (1) WO1996035434A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2273493T3 (en) * 1998-05-27 2007-05-01 Euro-Celtique S.A. USE OF PREPARATIONS FOR THE APPLICATION OF ANTISEPTIC AGENTS AND / OR AGENTS THAT FAVOR THE HEALING OF WOUNDS TO THE LOWER RESPIRATORY TRACT.
US6491175B1 (en) 2000-06-28 2002-12-10 Saad Taha Single piece closure for a pressurized container
JP4084329B2 (en) * 2004-03-31 2008-04-30 小林製薬株式会社 Liquid composition and method for producing the same
CN102526176B (en) * 2012-01-21 2013-10-30 保定冀中药业有限公司 Oral administration mineral medicine manufactured by liquorice aqueous extracts
JP6320616B1 (en) * 2017-08-22 2018-05-09 ヴェローチェ・バイオファーマ・エルエルシー Novel ophthalmic compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152808A (en) * 1982-03-05 1983-09-10 Kiyuushin Seiyaku Kk Collutorium composition
JPH06172192A (en) * 1992-12-10 1994-06-21 Masaya Ootsuka Aqueous disinfectant for vaginal and intraoral mucosa
JP4169804B2 (en) * 1994-06-10 2008-10-22 小林製薬株式会社 Iodine preparation with fragrance

Also Published As

Publication number Publication date
AU5515196A (en) 1996-11-29
JPH08301774A (en) 1996-11-19
TW363890B (en) 1999-07-11
CN1089589C (en) 2002-08-28
WO1996035434A1 (en) 1996-11-14
CN1183724A (en) 1998-06-03

Similar Documents

Publication Publication Date Title
KR100451269B1 (en) Pharmaceutical antacid composition for oral administration
EP1466003B1 (en) Herbal composition for improving oral hygiene, and methods of using same
CA2350450A1 (en) Flavour blend for masking unpleasant taste of zinc compounds
PL178331B1 (en) Liquid compositions for oral administration containing paroxetin resinate
JP4051717B2 (en) Biotin-containing oral solution
AU2002330645B2 (en) Composition comprising paracetamol and a bitterness masking component
JP5398102B2 (en) Oral or throat bactericidal composition
US20100028325A1 (en) New Combination Of Cationic Preservatives With Taste-Masking Components
JP2018104377A (en) Composition for oral cavity
KR19980703866A (en) Disinfectant Disinfectant for Throat
US20020114767A1 (en) Oral hygiene preparation for inhibiting halitosis
CN107582419B (en) A kind of mouthwash containing biological lysozyme
EP1294373B1 (en) Pharmaceutical disinfectants comprising usnic acid and essential oils
EP1150660B1 (en) Pharmaceutical effervescent formulation containing metamizol
KR20060120206A (en) Pharmaceutical oral preparations containing nonsteroidal anti-inflammatory agents and having excellent palatability
JPH0995457A (en) Composition for oral cavity containing sodium chloride and magnesium chloride
JP2000239153A (en) Internal medicine composition containing iron compound
JPH1036252A (en) Oral liquid medicine combined with belladonna (total) alkaloid
JP2000239154A (en) Internal medicine composition containing iron compound
JP2001172184A (en) Composition for common cold or influenza
CN1040620C (en) Preparation of koujiesu
JPH02264711A (en) Dentifrice composition
JP2003160459A (en) Methionase activity inhibitor and composition for oral cavity
CN118078690A (en) Oral care composition, preparation method and application thereof
CN118078689A (en) Oral composition, preparation method and application thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E601 Decision to refuse application